METTL3 and acute myeloid leukemia: METTL3 has been demonstrated to play a variety of biological roles in various diseases, including AML [41–46], and a newly reported small-molecule METTL3 inhibitor reduced AML cell growth and promoted AML cell differentiation and apoptosis [8].